Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 7, 2014; 20(25): 8092-8101
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8092
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8092
Metabolomic studies of human gastric cancer: Review
Naresh Doni Jayavelu, Nadav S Bar, Department of Chemical Engineering, Norwegian University of Science and Technology, N7491 Trondheim, Norway
Author contributions: Jayavelu ND, Bar NS designed the research; Jayavelu ND performed the research; Jayavelu ND wrote the paper; Bar NS supervised the research.
Supported by Research Council of Norway, NO.70174300
Correspondence to: Naresh Doni Jayavelu, Department of Chemical Engineering, Norwegian University of Science and Technology, Høgskoleringen 1, N7491 Trondheim, Norway. nareshd@chemeng.ntnu.no
Telephone: +47-7359-1559 Fax: +47-7359-6100
Received: May 19, 2013
Revised: July 20, 2013
Accepted: August 4, 2013
Published online: July 7, 2014
Revised: July 20, 2013
Accepted: August 4, 2013
Published online: July 7, 2014
Core Tip
Core tip: This article presents a short review on metabolomics as a tool for biomarker discovery in human gastric cancer, with a primary focus on its use as a predictor of anticancer drug chemosensitivity, diagnosis, prognosis, and metastasis.